PT1620085E - Utilização de derivados de ácido fenoxiacético para tratamento de bexiga hiperactiva - Google Patents

Utilização de derivados de ácido fenoxiacético para tratamento de bexiga hiperactiva Download PDF

Info

Publication number
PT1620085E
PT1620085E PT04722967T PT04722967T PT1620085E PT 1620085 E PT1620085 E PT 1620085E PT 04722967 T PT04722967 T PT 04722967T PT 04722967 T PT04722967 T PT 04722967T PT 1620085 E PT1620085 E PT 1620085E
Authority
PT
Portugal
Prior art keywords
phenoxyactic
acid derivatives
hyperactive bladder
bladder treatment
treatment
Prior art date
Application number
PT04722967T
Other languages
English (en)
Portuguese (pt)
Inventor
Yoshinobu Yamazaki
Masami Kojima
Original Assignee
Kissei Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33420009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT1620085(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DE10320084A external-priority patent/DE10320084A1/de
Priority claimed from DE2003123837 external-priority patent/DE10323837A1/de
Application filed by Kissei Pharmaceutical filed Critical Kissei Pharmaceutical
Publication of PT1620085E publication Critical patent/PT1620085E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT04722967T 2003-05-05 2004-03-24 Utilização de derivados de ácido fenoxiacético para tratamento de bexiga hiperactiva PT1620085E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10320084A DE10320084A1 (de) 2003-05-05 2003-05-05 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase
DE2003123837 DE10323837A1 (de) 2003-05-23 2003-05-23 Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase

Publications (1)

Publication Number Publication Date
PT1620085E true PT1620085E (pt) 2008-08-07

Family

ID=33420009

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04722967T PT1620085E (pt) 2003-05-05 2004-03-24 Utilização de derivados de ácido fenoxiacético para tratamento de bexiga hiperactiva

Country Status (26)

Country Link
US (1) US20040229947A1 (https=)
EP (1) EP1620085B1 (https=)
JP (1) JP4602969B2 (https=)
KR (1) KR101052804B1 (https=)
AR (1) AR044169A1 (https=)
AT (1) ATE401878T1 (https=)
AU (1) AU2004236596B2 (https=)
BR (1) BRPI0409980A (https=)
CA (1) CA2524023C (https=)
CL (1) CL2004000952A1 (https=)
CY (1) CY1108425T1 (https=)
DE (1) DE602004015272D1 (https=)
DK (1) DK1620085T3 (https=)
ES (1) ES2309513T3 (https=)
IL (1) IL171713A (https=)
MX (1) MXPA05011862A (https=)
MY (1) MY141756A (https=)
NZ (1) NZ543347A (https=)
PE (1) PE20050524A1 (https=)
PL (1) PL1620085T3 (https=)
PT (1) PT1620085E (https=)
RU (1) RU2342133C2 (https=)
SI (1) SI1620085T1 (https=)
TW (1) TWI351279B (https=)
UY (1) UY28306A1 (https=)
WO (1) WO2004098586A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI356699B (en) 2004-11-10 2012-01-21 Kissei Pharmaceutical Agent for treating interstitial cystitis and agent
CA2605298A1 (en) * 2005-04-26 2006-11-09 Kissei Pharmaceutical Co., Ltd. Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate
US7763654B2 (en) * 2005-04-26 2010-07-27 Kissei Pharmaceutical Co., Ltd. Crystal polymorph of hydroxynorephedrin derivative hydrochloride
EP1769792A1 (de) * 2005-09-30 2007-04-04 Boehringer Ingelheim Pharma GmbH & Co.KG Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden
EP4410295A3 (en) 2017-06-06 2024-10-16 Urovant Sciences GmbH Use of vibegron to treat overactive bladder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6262115B1 (en) * 1995-05-22 2001-07-17 Alza Coporation Method for the management of incontinence
US6720014B1 (en) * 1997-08-13 2004-04-13 Diversa Corporation Phytase-containing foodstuffs and methods of making and using them
MY126489A (en) * 1998-07-08 2006-10-31 Kissei Pharmaceutical Phenoxyacetic acid derivatives and medicinal compositions containing the same
US6410484B1 (en) * 1999-11-01 2002-06-25 Sumitomo Chemical Company, Limited 6-Hydroxy-5,6-dihydrouracil compound and herbicidal composition containing thereof
MXPA04002449A (es) * 2001-09-13 2004-07-23 Kissei Pharmaceutical Cristales de derivado de hidroxinorefedrina.

Also Published As

Publication number Publication date
ES2309513T3 (es) 2008-12-16
EP1620085A1 (en) 2006-02-01
CA2524023C (en) 2011-11-22
EP1620085B1 (en) 2008-07-23
CY1108425T1 (el) 2014-04-09
JP4602969B2 (ja) 2010-12-22
KR101052804B1 (ko) 2011-07-29
IL171713A (en) 2011-12-29
JP2006525318A (ja) 2006-11-09
DK1620085T3 (da) 2008-11-24
CA2524023A1 (en) 2004-11-18
US20040229947A1 (en) 2004-11-18
PE20050524A1 (es) 2005-07-07
CL2004000952A1 (es) 2005-03-04
WO2004098586A1 (en) 2004-11-18
ATE401878T1 (de) 2008-08-15
AU2004236596B2 (en) 2010-03-11
SI1620085T1 (sl) 2008-12-31
AR044169A1 (es) 2005-08-24
RU2005137701A (ru) 2006-06-10
UY28306A1 (es) 2004-12-31
KR20060009886A (ko) 2006-02-01
MXPA05011862A (es) 2006-02-17
MY141756A (en) 2010-06-30
NZ543347A (en) 2008-05-30
RU2342133C2 (ru) 2008-12-27
DE602004015272D1 (de) 2008-09-04
TW200509902A (en) 2005-03-16
PL1620085T3 (pl) 2009-01-30
BRPI0409980A (pt) 2006-05-09
TWI351279B (en) 2011-11-01
AU2004236596A1 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
CY2016046I2 (el) Κινοζολινονες ως αναστολεις της ανθρωπινης 3-κινασης δελτα της φωσφατιδυλοσιτολης
PT1506781E (pt) Composicao para tratamento vaginal
PL1708991T3 (pl) Pochodne sulfonoamidu do leczenia chorób
DE602005005810D1 (de) Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen
CY2017048I2 (el) Νεες φαρμακευτικες χρησεις των παραγωγων σταυροσπορινης
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
CR8226A (es) Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
CY2018006I2 (el) Θεραπευτικο σχημα κλαδριβινης για την θεραπευτικη αντιμετωπιση της σκληρυνσης κατα πλακας
EP1660436A4 (en) cathepsin inhibitors
ITMO20050195A1 (it) Macchina per il trattamento extracorporeo di sangue
PL378212A1 (pl) Inhibitory 3-hydroksylazy kynureninowej do leczenia cukrzycy
PT1620085E (pt) Utilização de derivados de ácido fenoxiacético para tratamento de bexiga hiperactiva
ATE448228T1 (de) Pyrrolopyrimidinderivate zur behandlung proliferativer krankheiten
FI20040180L (fi) Koostumus psoriasis-taudin hoitamiseksi
ZA200605302B (en) Use of pentadienoic acid derivatives for the treatment of hyperuricemia
IS8225A (is) 2-etoxý-3-fenýlprópíónsýruafleiður til að meðhöndla fitusjúkdóma
ATE433983T1 (de) Thiadibenzoazulenderivate zur behandlung von entzündlichen erkrankungen
NO20030716D0 (no) Stimulator for vagina
ITMI20050891A1 (it) Formulazioni per il trattamento di psoriasi
ITMI20051292A1 (it) Procedimento per la purificazione di imiquimod
ITFI20040148A1 (it) Preparato per il trattamento locale di distrofie cutanee
ES1054157Y (es) Higrotapon para puntero de gaita
FR2858206B1 (fr) Extensiometre de la peau